hydralazine has been researched along with Hyperlipemia in 6 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Approximately 1 in 5 hospitalized COPD patients are readmitted within 30 days of discharge." | 2.82 | Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions? ( Bowlin, B; Finch, C; Hartmann, J; Reedus, J; Richardson, A; Sands, CW; Self, T; Tolley, E, 2016) |
| "Hydralazine-treated STZ-diabetic rats had serum triglyceride and cholesterol levels that did not differ from controls." | 1.29 | Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus. ( Heyliger, CE; Powell, DM; Skau, KA, 1995) |
| "Enalapril treatment significantly reduced proteinuria (731 +/- 23 vs." | 1.29 | Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats. ( Baba, N; Sakemi, T, 1993) |
| "The treatment of both hyperlipidemia and hypertension appeared to be more effective than the treatment of hyperlipidemia, alone." | 1.26 | Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta. ( Hollander, W; Kirkpatrick, B; Madoff, I; Paddock, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardson, A | 1 |
| Tolley, E | 1 |
| Hartmann, J | 1 |
| Reedus, J | 1 |
| Bowlin, B | 1 |
| Finch, C | 1 |
| Sands, CW | 1 |
| Self, T | 1 |
| Spence, JD | 1 |
| Perkins, DG | 1 |
| Kline, RL | 1 |
| Adams, MA | 1 |
| Haust, MD | 1 |
| Heyliger, CE | 1 |
| Powell, DM | 1 |
| Skau, KA | 1 |
| Sakemi, T | 1 |
| Baba, N | 1 |
| Hollander, W | 1 |
| Madoff, I | 1 |
| Paddock, J | 1 |
| Kirkpatrick, B | 1 |
| Metelitsa, VI | 1 |
| Oganov, RG | 1 |
1 trial available for hydralazine and Hyperlipemia
| Article | Year |
|---|---|
Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme I | 2016 |
5 other studies available for hydralazine and Hyperlipemia
| Article | Year |
|---|---|
Hemodynamic modification of aortic atherosclerosis. Effects of propranolol vs hydralazine in hypertensive hyperlipidemic rabbits.
Topics: Animals; Aortic Diseases; Arteriosclerosis; Cholesterol; Hemodynamics; Hydralazine; Hyperlipidemias; | 1984 |
Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Carrier Proteins; Diabetes Mellitus, Experimental; Fatty Acid-Bind | 1995 |
Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats.
Topics: Animals; Antihypertensive Agents; Cholesterol; Drug Therapy, Combination; Enalapril; Hydralazine; Hy | 1993 |
Aggravation of atherosclerosis by hypertension in a subhuman primate model with coarctation of the aorta.
Topics: Animals; Aortic Coarctation; Arteriosclerosis; Blood Pressure; Body Weight; Cholesterol, Dietary; Co | 1976 |
System approach to testing hypotensive drugs for prevention of arterial hypertension.
Topics: Clinical Trials as Topic; Humans; Hydralazine; Hyperlipidemias; Hypertension; Prazosin; Propranolol | 1987 |